Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-028224)

Filing Details

Accession Number:: 0001209191-17-028224
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-26 17:02:14
Reporting Period:: 2017-04-24

Filing Date:: 2017-04-26
Accepted Time:: 2017-04-26 17:02:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339970	Atyr Pharma Inc	LIFE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238362	John Mendlein	3545 John Hopkins Court, Suite 250 San Diego CA 92121	Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-04-24	124	$3.00	327,647	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 21, 2016.